Literature DB >> 28590865

Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us.

Donna Spiegelman1, Tyler J VanderWeele1.   

Abstract

We provide an overview of the relative merits of ratio measures (relative risks, risk ratios, and rate ratios) compared with difference measures (risk and rate differences). We discuss evidence that the multiplicative model often fits the data well, so that rarely are interactions with other risk factors for the outcome observed when one uses a logistic, relative risk, or Cox regression model to estimate the intervention effect. As a consequence, additive models, which estimate the risk or rate difference, will often exhibit interactions. Under these circumstances, absolute measures of effect, such as years of life lost, disability- or quality-adjusted years of life lost, and number needed to treat, will not be externally generalizable to populations other than those with similar risk factor distributions as the population in which the intervention effect was estimated. Nevertheless, these absolute measures are often of the greatest importance in public health decision-making. When studies of high-risk study populations are used to more efficiently estimate effects, these populations will not be representative of the general population's risk factor distribution. The relative homogeneity of ratio versus absolute measures will thus have important implications for the generalizability of results across populations.

Entities:  

Mesh:

Year:  2017        PMID: 28590865      PMCID: PMC5463222          DOI: 10.2105/AJPH.2017.303810

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  24 in total

1.  Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization.

Authors:  L M Schwartz; S Woloshin; H G Welch
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

2.  Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes.

Authors:  Jonathan J Deeks
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer.

Authors:  Stephanie A Smith-Warner; Donna Spiegelman; John Ritz; Demetrius Albanes; W Lawrence Beeson; Leslie Bernstein; Franco Berrino; Piet A van den Brandt; Julie E Buring; Eunyoung Cho; Graham A Colditz; Aaron R Folsom; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Lisa Harnack; Pamela L Horn-Ross; Vittorio Krogh; Michael F Leitzmann; Marjorie L McCullough; Anthony B Miller; Carmen Rodriguez; Thomas E Rohan; Arthur Schatzkin; Roy Shore; Mikko Virtanen; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shumin M Zhang; David J Hunter
Journal:  Am J Epidemiol       Date:  2006-04-19       Impact factor: 4.897

4.  Lung cancer mortality and exposure to radon progeny in a cohort of New Mexico underground uranium miners.

Authors:  J M Samet; D R Pathak; M V Morgan; C R Key; A A Valdivia; J H Lubin
Journal:  Health Phys       Date:  1991-12       Impact factor: 1.316

5.  Is the Risk Difference Really a More Heterogeneous Measure?

Authors:  Charlie Poole; Ian Shrier; Tyler J VanderWeele
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

6.  Quantifying risk over the life course - latency, age-related susceptibility, and other time-varying exposure metrics.

Authors:  Molin Wang; Xiaomei Liao; Francine Laden; Donna Spiegelman
Journal:  Stat Med       Date:  2016-01-10       Impact factor: 2.373

7.  Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.

Authors:  Rulla M Tamimi; Donna Spiegelman; Stephanie A Smith-Warner; Molin Wang; Mathew Pazaris; Walter C Willett; A Heather Eliassen; David J Hunter
Journal:  Am J Epidemiol       Date:  2016-12-06       Impact factor: 4.897

8.  The effect of race and sex on physicians' recommendations for cardiac catheterization.

Authors:  K A Schulman; J A Berlin; W Harless; J F Kerner; S Sistrunk; B J Gersh; R Dubé; C K Taleghani; J E Burke; S Williams; J M Eisenberg; J J Escarce
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

Review 9.  Precision Public Health for the Era of Precision Medicine.

Authors:  Muin J Khoury; Michael F Iademarco; William T Riley
Journal:  Am J Prev Med       Date:  2015-11-04       Impact factor: 5.043

10.  The association of long-term exposure to PM2.5 on all-cause mortality in the Nurses' Health Study and the impact of measurement-error correction.

Authors:  Jaime E Hart; Xiaomei Liao; Biling Hong; Robin C Puett; Jeff D Yanosky; Helen Suh; Marianthi-Anna Kioumourtzoglou; Donna Spiegelman; Francine Laden
Journal:  Environ Health       Date:  2015-05-01       Impact factor: 5.984

View more
  10 in total

Review 1.  From Epidemiologic Knowledge to Improved Health: A Vision for Translational Epidemiology.

Authors:  Michael Windle; Hojoon D Lee; Sarah T Cherng; Catherine R Lesko; Colleen Hanrahan; John W Jackson; Mara McAdams-DeMarco; Stephan Ehrhardt; Stefan D Baral; Gypsyamber D'Souza; David W Dowdy
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

2.  Evaluating Public Health Interventions: 8. Causal Inference for Time-Invariant Interventions.

Authors:  Donna Spiegelman; Xin Zhou
Journal:  Am J Public Health       Date:  2018-07-19       Impact factor: 9.308

3.  Adjusted restricted mean survival times in observational studies.

Authors:  Sarah C Conner; Lisa M Sullivan; Emelia J Benjamin; Michael P LaValley; Sandro Galea; Ludovic Trinquart
Journal:  Stat Med       Date:  2019-05-22       Impact factor: 2.373

4.  Evaluating Public Health Interventions: 7. Let the Subject Matter Choose the Effect Measure: Ratio, Difference, or Something Else Entirely.

Authors:  Donna Spiegelman; Polyna Khudyakov; Molin Wang; Tyler J Vanderweele
Journal:  Am J Public Health       Date:  2017-11-21       Impact factor: 9.308

5.  Effect heterogeneity and variable selection for standardizing causal effects to a target population.

Authors:  Anders Huitfeldt; Sonja A Swanson; Mats J Stensrud; Etsuji Suzuki
Journal:  Eur J Epidemiol       Date:  2019-10-26       Impact factor: 8.082

6.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

7.  Treatment Effect Measures for Culture Conversion Endpoints in Phase IIb Tuberculosis Treatment Trials.

Authors:  Isabelle R Weir; Sean Wasserman
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

8.  Meta-regression methods to characterize evidence strength using meaningful-effect percentages conditional on study characteristics.

Authors:  Maya B Mathur; Tyler J VanderWeele
Journal:  Res Synth Methods       Date:  2021-08-26       Impact factor: 5.273

9.  The Interaction Continuum.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2019-09       Impact factor: 4.822

10.  Estimating the natural indirect effect and the mediation proportion via the product method.

Authors:  Chao Cheng; Donna Spiegelman; Fan Li
Journal:  BMC Med Res Methodol       Date:  2021-11-20       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.